Daisuke Usui
Geschäftsführer bei REPROCELL INCORPORATED
Vermögen: 146 259 $ am 30.04.2024
Profil
Daisuke Usui is currently the Chief Operating Officer & Director at ReproCELL, Inc. He is also a Director at ReproCELL USA, Inc., RC Partners, Inc., ReproCELL Europe Ltd., and MAGiQ Therapeutics KK.
Previously, he served as the Chief Executive Officer at Reinnervate Ltd.
Mr. Usui completed his undergraduate degree at the University of Tsukuba.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPROCELL INC.
0,19% | 31.03.2023 | 168 000 ( 0,19% ) | 146 259 $ | 30.04.2024 |
Aktive Positionen von Daisuke Usui
| Unternehmen | Position | Beginn |
|---|---|---|
| REPROCELL INCORPORATED | Geschäftsführer | 11.11.2020 |
RC Partners, Inc.
 RC Partners, Inc. Investment ManagersFinance RC Partners, Inc. engages in the operation and management of investment funds. The company was founded on February 12, 2014 and is headquartered in Yokohama, Japan. | Direktor/Vorstandsmitglied | 01.06.2016 |
ReproCELL Europe Ltd.
 ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Direktor/Vorstandsmitglied | 01.07.2016 |
ReproCELL USA, Inc.
 ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Direktor/Vorstandsmitglied | 01.09.2016 |
| MAGiQ Therapeutics KK | Direktor/Vorstandsmitglied | 01.12.2019 |
Ehemalige bekannte Positionen von Daisuke Usui
| Unternehmen | Position | Ende |
|---|---|---|
Reinnervate Ltd.
 Reinnervate Ltd. BiotechnologyHealth Technology Reinnervate Ltd. operates as a life sciences company that develops, manufactures, and sells products for three dimensional (3D) cell culture applications that include cancer research, drug discovery, HTS, stem cell biology, and others. It offers Alvetex, a porous polystyrene scaffold designed for 3D cell culture. The company was founded by Stefan A. Przyborski in 2002 and is headquartered in Sedgefield, the United Kingdom. | Vorstandsvorsitzender | - |
Ausbildung von Daisuke Usui
| University of Tsukuba | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REPROCELL INCORPORATED | Health Technology |
| Private Unternehmen | 5 |
|---|---|
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance RC Partners, Inc. engages in the operation and management of investment funds. The company was founded on February 12, 2014 and is headquartered in Yokohama, Japan. | Finance |
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Reinnervate Ltd. operates as a life sciences company that develops, manufactures, and sells products for three dimensional (3D) cell culture applications that include cancer research, drug discovery, HTS, stem cell biology, and others. It offers Alvetex, a porous polystyrene scaffold designed for 3D cell culture. The company was founded by Stefan A. Przyborski in 2002 and is headquartered in Sedgefield, the United Kingdom. | Health Technology |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Commercial Services |
ReproCELL USA, Inc.
ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Health Services |
| MAGiQ Therapeutics KK |
